Investor Presentaiton

2018 In-House Injectable Plant Progress First Half Second Half ✓ Complete equipment/ sterility verification and CGMP system deployment for both vial and cartridge production lines ✓ Complete registration batch production for liquid solution/lyophized powder/prefilled-syringe and pen decvece ✓ Kick-off registration batch production for other products and offering CMO services for both brand and proprietary drugs ✓ Expected submission of 1st in-house produced ANDA ✓ Taiwan FDA on-site inspection 26 26 ScinoPharm

View entire presentation